General Information of Drug Transporter (DT)
DT ID DTD0095 Transporter Info
Gene Name SLC13A5
Transporter Name Sodium-coupled citrate transporter
Gene ID
284111
UniProt ID
Q86YT5

Transcriptional Regulation of This DT (TSR)

TF Superclass1: Basic domains

      Class1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        CREB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC13A5 gene [1]

TF Protein Name

Cyclic AMP-responsive element-binding protein 1 Transcription Factor Info

Tissue

Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter.

      Class1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        AHR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC13A5 gene in health condition [2]

TF Protein Name

Aryl hydrocarbon receptor Transcription Factor Info

Affected Drug/Substrate

Citrate

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

Wistar rats

Detailed Description

Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of SLC13A5 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled citrate transporter.

        TCF3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC13A5 gene [3]

TF Protein Name

Transcription factor E2-alpha Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2-alpha (TCF3) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter.

      Class1.3: Basic helix-span-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        TFAP2A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC13A5 gene in MCF7 cells [4]

TF Protein Name

Transcription factor AP-2-alpha Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Transcription factor AP-2-alpha (TFAP2A) has been reported to bind to the transcription of SLC13A5 gene in MCF7 cells, which leads to an affected expression of the drug transporter Sodium-coupled citrate transporter.

TF Superclass2: Zinc-coordinating DNA-binding domains

      Class2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        AR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC13A5 gene in prostate cancer condition [5]

TF Protein Name

Androgen receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Androgen receptor (AR) has been reported to bind to the transcription of SLC13A5 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium-coupled citrate transporter.

        HNF4A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC13A5 gene in health condition [6]

TF Protein Name

Hepatocyte nuclear factor 4-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC13A5 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled citrate transporter.

        NR1I2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC13A5 gene in health condition [7]

TF Protein Name

Nuclear receptor subfamily 1 group I member 2 Transcription Factor Info

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

human primary hepatocyte isolates

Detailed Description

Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of SLC13A5 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled citrate transporter.

      Class2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC13A5 gene [3]

TF Protein Name

Myc-associated zinc finger protein Transcription Factor Info

Tissue

Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myc-associated zinc finger protein (MAZ) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter.

TF Superclass3: Helix-turn-helix domains

      Class3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        E2F6 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC13A5 gene [8]

TF Protein Name

Transcription factor E2F6 Transcription Factor Info

Tissue

Bone marrow; Embryo; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2F6 (E2F6) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter.

      Class3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        GABPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC13A5 gene [9]

TF Protein Name

GA-binding protein alpha chain Transcription Factor Info

Tissue

Embryo; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

GA-binding protein alpha chain (GABPA) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter.

        SPI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC13A5 gene [1]

TF Protein Name

Transcription factor PU.1 Transcription Factor Info

Tissue

Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor PU.1 (SPI1) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter.

TF Superclass6: Immunoglobulin fold

      Class6.5: T-Box factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        EOMES 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC13A5 gene in health condition [10]

TF Protein Name

Eomesodermin homolog Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Eomesodermin homolog (EOMES) has been reported to activate the transcription of SLC13A5 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled citrate transporter.
References
1 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-300. (ID:ENSG00000141485)
2 Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes. Toxicology. 2015 Nov 4;337:1-9.
3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
4 A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1. Genome Res. 2006;16(12):1585-95.
5 Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor. PLoS One. 2009;4(8):e6589.
6 Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 2009;37(22):7498-508.
7 Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes. Cells. 2021 Dec 1;10(12):3381.
8 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
9 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
10 Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev. 2011;25(3):238-50.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.